People: Laboratory Corporation of America Holdings (LH)


LH on New York Consolidated

100.78USD
18 Jun 2013
Price Change (% chg)

$0.34 (+0.34%)
Prev Close
$100.44
Open
$100.48
Day's High
$100.90
Day's Low
$100.19
Volume
384,072
Avg. Vol
840,741
52-wk High
$101.69
52-wk Low
$82.15

Search Stocks

Summary

Name Age Since Current Position

David King

 56 2009 Chairman of the Board, President, Chief Executive Officer

William Hayes

 47 2005 Chief Financial Officer, Executive Vice President, Treasurer

James Boyle

 56 2009 Chief Operating Officer, Executive Vice President

F. Samuel Eberts

 53 2009 Senior Vice President, Chief Compliance Officer, Secretary, Chief Legal Officer

Mark Brecher

 57 2009 Senior Vice President, Chief Medical Officer

Robert Mittelstaedt

 69 2009 Lead Independent Director

Kerrii Anderson

 55 2006 Independent Director

Jean-Luc Belingard

 64 1995 Independent Director

Wendy Lane

 62 1996 Independent Director

Peter Neupert

 52 2013 Independent Director

Arthur Rubenstein

 75 2004 Independent Director

Adam Schechter

 48 2013 Independent Director

M. Keith Weikel

 75 2003 Independent Director

R. Sanders Williams

 64 2007 Independent Director

Stephen Anderson

 Vice President, Investor Relations
» Insider Trading

Biographies

Name Description

David King

 Mr. David P. King serves as Chairman of the Board, President, Chief Executive Officer of Laboratory Corporation of America Holdings. He has served as Chairman of the Board, President, and Chief Executive Officer of the Company since May 6, 2009; prior to that date he served as a director, President and Chief Executive Officer of the Company since January 1, 2007. Mr. King served as Executive Vice President and Chief Operating Officer from December 2005 to January 2007, as Executive Vice President of Strategic Planning and Corporate Development from January 2004 to December 2005 and was hired in September 2001 as Senior Vice President, General Counsel and Chief Compliance Officer. Prior to joining the Company, he was a partner with Hogan & Hartson LLP (now Hogan Lovells US LLP) in Baltimore, Maryland from 1992 to 2001. Mr. King was appointed to the board of directors of Cardinal Health, Inc. in 2011 .

William Hayes

 Mr. William B. Hayes serves as Executive Vice President, Chief Financial Officer and Treasurer of Laboratory Corporation of America Holdings. He has served as Executive Vice President, Chief Financial Officer and Treasurer since June 2005. Mr. Hayes served as Senior Vice President, Investor Relations from July 2004 to June 2005. Prior to this date, Mr. Hayes was Senior Vice President, Finance since 2000. Mr. Hayes is responsible for the day-to-day supervision of the finance and billing functions of the Company. Prior to joining the Company in 1996, Mr. Hayes was in the audit department at KPMG LLP for 9 years.

James Boyle

 Mr. James T. Boyle, Jr., serves as Chief Operating Officer, Executive Vice President of Laboratory Corporation of America Holdings. He is responsible for the day-to-day supervision of all operations and sales of the Company. Prior to October 2009, Mr. Boyle was Senior Vice President, Managed Care since May 2006. In December of 2008, Mr. Boyle also assumed operating responsibility for the Company’s Occupational Testing/Employer Group Services in his then current role of Senior Vice President of Managed Care/OTS. Mr. Boyle previously held the position of Vice President of Managed Care from August 2004 to May 2006. Prior to that Mr. Boyle was the Director of Litigation and Assistant General Counsel from 1999 to 2004. Prior to joining the Company in 1999, Mr. Boyle was engaged in the private practice of law for more than 15 years, specializing in litigation.

F. Samuel Eberts

 Mr. F. Samuel Eberts, III., serves as Senior Vice President, Chief Legal Officer, Secretary and Chief Compliance Officer of Laboratory Corporation of America Holdings., since January 1, 2009. Prior to that time he served as Senior Vice President, General Counsel since August 2004. Prior to joining the Company, he was Vice President, Secretary, and General Counsel of Stepan Company. Before joining Stepan Company, he was Assistant General Counsel for Cardinal Health, Inc. from 1998 to 2001 and Associate General Counsel for Allegiance Healthcare Corporation (Allegiance Healthcare Corporation was purchased by Cardinal Health in 1998). Prior to that time, he was Chief Counsel of the Biotech North America division of Baxter International Inc.

Mark Brecher

 Dr. Mark Elliott Brecher, M.D., serves as Senior Vice President, Chief Medical Officer of Laboratory Corporation of America Holdings. He joined the Company in March 2009 as Senior Vice President, Chief Medical Officer. Prior to joining the Company, Dr. Brecher served as Vice Chair of the Department of Pathology and Laboratory Medicine at the McLendon Clinical Laboratories, University of North Carolina Hospitals from July 2006 to February 2009. From July 2003 to July 2006, Dr. Brecher was the Acting Director of the Laboratory Information Systems and the Director of Clinical Pathology. Dr. Brecher is a member of the editorial board of Transfusion and is an associate editor of the Journal of Clinical Apheresis. He is a past chair of the Department of Health and Human Services Advisory Committee on Blood Safety and Availability and a past president of the American Society for Apheresis.

Robert Mittelstaedt

 Mr. Robert E. Mittelstaedt, Jr., serves as Lead Independent Director of Laboratory Corporation of America Holdings. He has served as a director of the Company since November 1996. Mr. Mittelstaedt is Dean Emeritus and Professor of Management of the W.P. Carey School of Business at Arizona State University. Prior to June 30, 2004, he was Vice Dean, Executive Education of The Wharton School, University of Pennsylvania. Mr. Mittelstaedt had served with The Wharton School since 1973, with the exception of the period from 1985 to 1989 when he founded, served as President and Chief Executive Officer, and subsequently sold Intellego, Inc., a company engaged in practice management, systems development, and service bureau billing operations in the medical industry. Mr. Mittelstaedt serves as a director and Compensation Committee chair of W.P. Carey & Co., LLC and also serves as a director and Compensation Committee member of Innovative Solutions & Support, Inc.

Kerrii Anderson

 Ms. Kerrii B. Anderson serves as an Independent Director of Laboratory Corporation of America Holdings. She has served as a director of the Company since May 17, 2006. Ms. Anderson was Chief Executive Officer of Wendy’s International, Inc., a restaurant operating and franchising company from April 2006 until September 2008 when the company was merged with Triarc. Ms. Anderson served as Executive Vice President and Chief Financial Officer of Wendy’s International from 2000 to 2006. Prior to this position, she was Chief Financial Officer, Senior Vice President of M/I Schottenstein Homes, Inc. from 1987 to 2000. Ms. Anderson is the Chairwoman of the Board of Chiquita Brands International Inc. since October 2012, and the Chairwoman of the Nominating and Corporate Governance Committee and a member of the Compensation Committee. She is also a director and a member of the Compensation Committee and Audit Committee of Worthington Industries, Inc. Ms. Anderson serves on the financial committee of Columbus Foundation and Board of Trustees of Ohio Health and Board of Trustees for Elon University and chairs the Audit Committee for Elon. She also was a director of PF Chang’s China Bistro, Inc. from 2010 until June 2012 and Wendy’s International from 2006 until September 30, 2008.

Jean-Luc Belingard

 Mr. Jean-Luc Belingard serves as an Independent Director of Laboratory Corporation of America Holdings. He has served as a director of the Company since April 28, 1995. Since 2011, Mr. Bélingard has been Chairman of bioMérieux. Since July 2011, Mr. Bélingard has also taken over the CEO position of bioMérieux. Mr. Bélingard retired as Chairman and Chief Executive Officer of Ipsen SA, a diversified French health care holding company, on November 22, 2010. He had served in that position since 2001. Prior to this position, Mr. Bélingard was Chief Executive Officer from 1999 to 2001 of bioMérieux-Pierre Fabre, a diversified French health care holding company, where his responsibilities included the management of that company’s worldwide pharmaceutical and cosmetic business. Mr. Bélingard is also a director of Stallergenes (France). Mr. Bélingard was also a director of Celera Corporation, a former division of Applera Corporation, Norwalk, Connecticut from May 2008 to May 2010. Mr. Bélingard served as a director and member of the Audit Committee of Nicox (France) from December 2002 to August 2010. Mr. Bélingard was a director of Applera Corporation, Norwalk, Connecticut from 1993 to June 2008. From 1990 to 1999, Mr. Bélingard was CEO of Roche Diagnostics and a member of the Hoffman La Roche group Executive Committee.

Wendy Lane

 Ms. Wendy E. Lane serves as an Independent Director of Laboratory Corporation of America Holdings. Ms. Lane has been Chairman of Lane Holdings, Inc., an investment firm, since 1992. Prior to forming Lane Holdings, Inc., Ms. Lane was a Principal and a Managing Director of Donaldson, Lufkin & Jenrette, an investment banking firm, serving in these and other positions from 1980 to 1992. Ms. Lane is a director and sits on the Executive Committee of the Board of Directors of Willis Group Holdings, Ltd. and is also an Audit Committee member, chairs the Compensation Committee and has sat on special Committees. She is also a director and member of the Audit Committee of UPM-Kymmene Corporation.

Peter Neupert

 Mr. Peter M. Neupert serves as an Independent Director of Laboratory Corporation of America Holdings. Mr. Neupert has been an Operating Partner at Health Evolution Partners, a health only, middle market private equity firm, since January 2012. Prior to that, Mr. Neupert served as Corporate Vice President of the Microsoft Health Solutions Group from its formation in 2005 to January 2012. Mr. Neupert served on the President’s Information Technology Advisory Committee (PITAC) co-chairing the Health Information Technology subcommittee, helping to drive the “Revolutionizing Health Care Through Information Technology” report, published in June 2004. Mr. Neupert served as the founding President and Chief Executive Officer of drugstore.com from 1998 to 2001 and as Chairman of the Board of Directors through September 2004. He serves as a trustee for the Fred Hutchinson Cancer Research Center and was an active member of the Institute of Medicine’s Roundtable on Value & Science-Driven Healthcare from 2007-2011.

Arthur Rubenstein

 Dr. Arthur H. Rubenstein, MBBCh, serves as an Independent Director of Laboratory Corporation of America Holdings. He has served as a director of the Company since August 1, 2004. Dr. Rubenstein was the Dean of the University of Pennsylvania School of Medicine and Executive Vice President for the University of Pennsylvania Health System from 2001 until June 31, 2011. Previously, Dr. Rubenstein was Dean and Gustave L. Levy Distinguished Professor at the Mount Sinai School of Medicine in New York from 1997 to 2001. He has also been a faculty member and chairman of the Department of Medicine at the University of Chicago. He is a distinguished member of the American Academy of Arts and Sciences and the American Association for the Advancement of Science. Dr. Rubenstein serves as a director of Glycadia and is Chair of the Medical/Scientific Board of Catabasis Pharmaceuticals, Inc. He served as a director of Diasome from May 2009 to June 2011.

Adam Schechter

 Mr. Adam H. Schechter has been appointed as Independent Director of Laboratory Corporation of America Holdings., effective April 1, 2013. Mr. Schechter is an Executive Vice President of Merck & Co., Inc. and the President of Merck’s Global Human Health Division since 2010, which includes the company’s worldwide pharmaceutical and vaccine businesses. He is a member of Merck’s executive committee and pharmaceutical and vaccines operating committee. Prior to becoming President, Global Human Health, Mr. Schechter served as President, Global Pharmaceutical Business from 2007 to 2010. Mr. Schechter’s experience at Merck includes global and U.S.-focused leadership roles spanning sales, marketing, and managed markets, as well as business and product development. Mr. Schechter serves on the board of directors for the European Federation of Pharmaceutical Industries and Associations. He is a Board Member for Water.org and an Executive Board Member for the National Alliance for Hispanic Health.

M. Keith Weikel

 Dr. M. Keith Weikel, Ph.D., serves as an Independent Director of Laboratory Corporation of America Holdings. He has served as a director of the Company since July 16, 2003. On December 31, 2006, Dr. Weikel retired as Senior Executive Vice President and Chief Operating Officer of Manor Care, Inc., a health-care provider, where he began his career in 1984 with Manor HealthCare Corporation, an operating subsidiary of Manor Care, Inc. Dr. Weikel is currently a member of the Federation of American Hospitals and the Alliance for Quality Long-term Care and serves as Director Emeritus for Manor Care, Inc. and as a director for Direct Supply, Inc.

R. Sanders Williams

 Dr. R. Sanders Williams, M.D., serves as an Independent Director of Laboratory Corporation of America Holdings. He has served as a director of the Company since May 16, 2007. Dr. Williams is President of The J. David Gladstone Institutes and Professor of Medicine at the University of California San Francisco. Prior to this appointment, Dr. Williams served Duke University between 2001 and 2010 as Dean of the School of Medicine, Senior Vice Chancellor, Senior Advisor for International Strategy, and founding Dean of the Duke-NUS Graduate Medical School Singapore. He has served previously as President of the Association of University Cardiologists, Chairman of the Research Committee of the American Heart Association, on the editorial boards of biomedical journals, on the Advisory Committee to the Director of the National Institutes of Health and on the Board of External Advisors of the National Heart, Lung and Blood Institute. He is a Director of Bristol-Myers Squibb Company, however on January 22, 2013, Dr. Williams notified Bristol-Meyers Squibb Company that he will not stand for re-election to the Board of Directors at the 2013 Annual Meeting of Stockholders, which is expected to be held in May 2013. Dr. Williams is also a member of the Institute of Medicine of the National Academy of Sciences, and a Fellow of the American Association for the Advancement of Science.

Stephen Anderson

Insider Trading

Name Shares Traded Price

BOYLE JAMES T JR

 63,100 $99.63

BOYLE JAMES T JR

 63,100 $70.15

BRECHER MARK E

 14,900 $70.15

BRECHER MARK E

 16,900 $100.92

BELINGARD JEAN LUC

 60 $100.37

HAYES WILLIAM B

 55,000 $100.00

HAYES WILLIAM B

 72,200 $100.00

HAYES WILLIAM B

 72,200 $75.63

HAYES WILLIAM B

 55,000 $80.37

EBERTS F SAMUEL III

 10,000 $47.89

EBERTS F SAMUEL III

 10,000 $98.47

BELINGARD JEAN LUC

 54 $95.01

BOYLE JAMES T JR

 68,908 $93.82

BOYLE JAMES T JR

 47,400 $60.04

BOYLE JAMES T JR

 3,334 $47.89

BOYLE JAMES T JR

 10,000 $58.57

BELINGARD JEAN LUC

 2,536 $30.36

BELINGARD JEAN LUC

 2,536 $92.88

WEIKEL M KEITH

 2,046 $31.35

WEIKEL M KEITH

 500 $92.92

WEIKEL M KEITH

 100 $92.93

WEIKEL M KEITH

 1,446 $92.90

LANE WENDY E

 1,268 $30.36

LANE WENDY E

 8 $93.75

LANE WENDY E

 6 $93.75
» Full list on Insider Trading
Search Stocks